{"id":4949,"date":"2026-06-18T19:25:00","date_gmt":"2026-06-18T19:25:00","guid":{"rendered":"https:\/\/conneqthealth.com\/insights\/?p=4949"},"modified":"2026-06-18T19:25:02","modified_gmt":"2026-06-18T19:25:02","slug":"lpa-test-result","status":"publish","type":"post","link":"https:\/\/conneqthealth.com\/insights\/lpa-test-result\/","title":{"rendered":"Lp(a): What The Test Shows and What to Do With the Result"},"content":{"rendered":"\n

Lp(a) is a genetically determined cholesterol particle that lifestyle can’t change. Standard lipid panels don’t include it, even though guidelines now recommend testing every adult once. Here’s why it matters for the rest of your cardiovascular health.<\/h2>\n\n\n\n
\n

In a Heartbeat<\/h2>\n\n\n\n

What is Lp(a)? <\/strong>Lp(a) is a cholesterol particle you inherit from your parents. Unlike LDL, when elevated, it raises cardiovascular risk in ways that standard cholesterol panels don’t capture.<\/p>\n\n\n\n

Why does it matter? <\/strong>Roughly one in five adults has an elevated level. Lifestyle changes and standard cholesterol medications do not lower it. The number is set by your genetics and stays stable across your lifetime.<\/p>\n\n\n\n

What an elevated result means: <\/strong>An elevated Lp(a) is not a diagnosis. It tells you that your baseline genetic risk is higher than average, which means the risk factors you can change carry more weight in your overall heart health picture.<\/p>\n\n\n\n

What to ask your clinician: <\/strong>Has Lp(a) ever been part of your lipid panel? If your result comes back elevated, ask how it changes your overall risk and which other risk factors should be managed more tightly as a result.<\/p>\n<\/div>\n\n\n\n

You may have heard recently that there’s a cholesterol test you should be asking your clinician about.<\/p>\n\n\n\n

Or you may have already had it done, and the result came back with a number you don’t quite know how to interpret.<\/p>\n\n\n\n

Either way, you’re probably looking for a clear explanation of what Lp(a) is, what your Lp(a) test result actually tells you, and what to do with the information.<\/p>\n\n\n\n

The Lp(a) test is not currently included in a standard cholesterol panel. It has to be ordered separately. Until recently, very few people were tested for it outside of specialized cardiology offices.<\/p>\n\n\n\n

That is changing. The National Lipid Association issued a focused update in 2024<\/a> recommending that every adult have Lp(a) measured at least once. The 2026 ACC\/AHA Cholesterol Guidelines<\/a> brought the same recommendation into mainstream practice.<\/p>\n\n\n\n

There is more to the Lp(a) story than the recommendation itself.<\/p>\n\n\n\n

What Lp(a) actually is<\/strong><\/h2>\n\n\n\n

Lp(a), pronounced “L-P-little-a,” is a type of cholesterol particle. Its full name is lipoprotein(a).

It looks a lot like LDL, the cholesterol you may already know about. But it has an extra protein attached, called apolipoprotein(a). That extra protein is what makes Lp(a) different, and what makes it matter.<\/p>\n\n\n\n

Two things set Lp(a) apart from LDL.<\/p>\n\n\n\n

The first is genetics. Your Lp(a) level is more than 90% determined by your DNA. It stays remarkably stable across your lifetime. Diet, exercise, weight loss, and standard cholesterol medications do not meaningfully change it.

This is the part most people find surprising. Almost everything else you have learned about cholesterol involves things you can do to change your numbers. Lp(a) breaks that pattern.<\/p>\n\n\n\n

The second is how it behaves in the arteries. Recent genetic analyses<\/a> suggest that Lp(a) particles are more atherogenic than LDL particles<\/a>, particle for particle. In plain terms, each Lp(a) particle in your bloodstream appears to carry more cardiovascular risk than a comparable LDL particle.<\/p>\n\n\n\n

Roughly one in five adults<\/a> has an elevated Lp(a) level.

The average level varies by ancestry. People of African descent tend to have the highest averages. People from East and Southeast Asia tend to have the lowest. But the cardiovascular risk associated with elevated Lp(a) appears to be similar across populations, which is why current guidelines recommend testing all adults rather than only certain groups.<\/p>\n\n\n\n

Why your standard cholesterol panel doesn’t show it<\/strong><\/h2>\n\n\n\n

A standard lipid panel measures total cholesterol, LDL, HDL, and triglycerides.<\/p>\n\n\n\n

It does not measure Lp(a).<\/p>\n\n\n\n

The Lp(a) test is a separate blood test that has to be ordered specifically. For decades, that order was made mostly for patients with early heart disease, strong family histories, or unexplained cardiovascular risk despite normal standard lipids. Insurance coverage for the Lp(a) test varies by plan and is worth checking with your insurer before ordering.<\/p>\n\n\n\n

Even now, with the recent guideline shift, Lp(a) testing is still uncommon in routine practice.<\/p>\n\n\n\n

A 2025 analysis of US electronic health records<\/a> covered more than 300 million people. It found that despite growing awareness, Lp(a) testing remains rare. The gap between what guidelines recommend and what gets ordered is closing, but slowly.<\/p>\n\n\n\n

The case for Lp(a) screening every adult rests on three things. Elevated Lp(a) is common, affecting roughly one in five people. It adds cardiovascular risk that conventional lipid markers miss. And a single measurement gives you a result you can rely on essentially for life, because Lp(a) levels stay stable across decades.<\/p>\n\n\n\n

What your Lp(a) result means<\/strong><\/h2>\n\n\n\n

Two things determine what your Lp(a) result tells you: how the lab reports it, and what the number means in context.<\/p>\n\n\n\n

How your result is reported<\/strong><\/h3>\n\n\n\n

Your Lp(a) result will come back in one of two units.<\/p>\n\n\n\n

Some labs report it in milligrams per deciliter (mg\/dL), which measures the mass of Lp(a) in your blood. Others report it in nanomoles per liter (nmol\/L), which measures the number of particles. The two units are not directly interchangeable. Particle size varies between people, so the same mg\/dL value can mean different particle counts in different individuals.<\/p>\n\n\n\n

Most current cardiology guidance prefers nmol\/L. Particle count tends to predict cardiovascular risk better than mass. If your result is reported in mg\/dL, ask your clinician what the particle-count equivalent is.<\/p>\n\n\n\n

What counts as elevated<\/strong><\/h3>\n\n\n\n

Different guidelines use different cutoffs.<\/p>\n\n\n\n

The 2024 National Lipid Association update<\/a> categorizes risk on a continuum. Low risk falls below 75 nmol\/L. High risk starts at 125 nmol\/L or above. The European Atherosclerosis Society uses overlapping but not identical thresholds.<\/p>\n\n\n\n

The important thing is that these are reference points, not hard cutoffs. The relationship between Lp(a) and cardiovascular risk is continuous. A reading of 130 nmol\/L is not a different category from 124 nmol\/L. The higher your number, the higher the associated risk, and the rise becomes steeper at the upper end.<\/p>\n\n\n\n

Population studies show that adults with the highest Lp(a) levels have meaningfully elevated cardiovascular event risk over decades.

The Women’s Health Study<\/a> followed nearly 28,000 women for 30 years and found that a single Lp(a) measurement taken at the start predicted cardiovascular events three decades later.

A separate analysis of more than 27,000 US adults<\/a> across five major cohorts confirmed the same gradient. Higher Lp(a), higher event risk, consistently across ethnic groups.<\/p>\n\n\n\n

This is why current guidelines describe Lp(a) as something you measure once and use for the rest of your life.<\/p>\n\n\n\n

Here is the part to hold on to.<\/p>\n\n\n\n

An elevated Lp(a) result is information about one specific contributor to your cardiovascular risk. It is not a diagnosis. And it is not a measure of your total cardiovascular risk.<\/p>\n\n\n\n

What it tells you is that your baseline genetic risk is higher than average, all else equal. It does not predict whether or when you will have a cardiovascular event. People with elevated Lp(a) can live long, healthy lives, particularly when they manage other risk factors well.<\/p>\n\n\n\n

An elevated Lp(a) is information you can act on. It is not a verdict about your future.<\/p>\n\n\n\n

What to do with the result<\/strong><\/h2>\n\n\n\n

If you have learned your Lp(a) is elevated, you probably want to know how to lower it.<\/p>\n\n\n\n

The honest answer is that you cannot.<\/p>\n\n\n\n

Diet, exercise, weight loss, better sleep, and stress management do not move Lp(a) in any meaningful way. Standard cholesterol medications, including statins, do not lower it either. Statins may actually raise it slightly.<\/p>\n\n\n\n

This is not because lifestyle does not matter for cardiovascular health. It matters enormously. It is because Lp(a) itself is determined almost entirely by genetics.<\/p>\n\n\n\n

So if knowing your number does not let you lower it, what is it for?<\/p>\n\n\n\n

Why knowing your number matters<\/strong><\/h3>\n\n\n\n

Knowing your Lp(a) does not change Lp(a). It changes how aggressively you manage everything else.<\/p>\n\n\n\n

A high Lp(a) raises your baseline cardiovascular risk. That means the other risk factors you can change, your LDL cholesterol, your blood pressure, your weight, your activity level, your sleep, your stress, and whether you smoke, all carry more weight in your cardiovascular risk. Tighter LDL control becomes especially important.<\/p>\n\n\n\n

This is the practical takeaway. A high result is a reason to take the other risk factors more seriously. It is not a separate problem to solve.<\/p>\n\n\n\n

A clinician looking at an elevated Lp(a) result will typically reassess your overall cardiovascular risk picture. They may tighten your LDL targets or discuss whether additional therapies like PCSK9 inhibitors are appropriate based on your full risk profile. They may also recommend testing your first-degree relatives, because Lp(a) is genetic, and elevated levels often run in families. Research shows that nearly half of first-degree relatives<\/a> of someone with elevated Lp(a) also have elevated levels themselves.<\/p>\n\n\n\n

The conversation is not about treating Lp(a) directly. It is about recalibrating everything else in light of what your result tells you about your starting point.<\/p>\n\n\n\n

Emerging treatments<\/strong><\/h3>\n\n\n\n

A new class of medications designed specifically to lower Lp(a) is in late-stage clinical trials. None of them are currently FDA-approved. None are available outside of research settings. The cardiovascular community is watching the results closely, and the next few years may produce the first approved therapy. But that is not the standard of care today.<\/p>\n\n\n\n

Lp(a) is one piece of the picture, not the whole picture<\/strong><\/h2>\n\n\n\n

An Lp(a) test tells you about one genetic contributor to your cardiovascular risk. It is a one-time test, not something you track over time.<\/p>\n\n\n\n

It does not tell you what is happening in your arteries today. Other measurements fill in different parts of the picture.<\/p>\n\n\n\n

A standard lipid panel and an ApoB measurement show what is circulating in your blood right now. Your blood pressure shows the mechanical load that circulation is putting on your arteries. Arterial function tracking goes one layer deeper, into how stiff your arterial walls are becoming and how efficiently your heart is delivering blood to the rest of your body. Each measurement adds something the others cannot. Combined, they show you what no single measurement can.<\/p>\n\n\n\n

The CONNEQT Pulse<\/a> tracks the arterial function layer. What it adds is an ongoing view of what your arterial system is doing day to day. It does not measure Lp(a), and it does not replace the blood test your clinician will order for that.<\/p>\n\n\n\n

For someone who already knows their Lp(a) is elevated, that ongoing view is worth having. It is one of the ways to see whether your cardiovascular health is trending in the right direction.<\/p>\n\n\n\n

What to take from this<\/strong><\/h2>\n\n\n\n

Lp(a) testing is becoming part of standard cardiovascular care because the evidence behind it has matured.<\/p>\n\n\n\n

For most people, it is a one-time test. The result stays useful for the rest of your life.<\/p>\n\n\n\n

Knowing your number is the first step. What you do with it is the part that matters.<\/p>\n\n\n\n

What to read next<\/strong><\/h2>\n\n\n\n

Now that you have a clearer sense of what your Lp(a) result means, these articles can help you put it in context.<\/p>\n\n\n\n